Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin versus placebo during laparoscopic endometrioma surgery for ovarian reserve preservation
IRCT20200825048515N26Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in endometrioma comparing Vasopressin injection with Placebo saline injection (2 arms). Primary endpoints: Number of antral ovarian follicles and Serum anti-Mullerian hormone level. Started Mar 2021; status: completed.
02
Drugs
vasopressin
03
Conditions
endometrioma
Beyond the preview
Go deeper on IRCT20200825048515N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N26.